









Markets
/
Stocks
/
nasdaq-neog
/

Neogen Corp

NEOG

5.670USD

+0.210+3.85%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

1.23BMarket Cap

LossP/E TTM



Neogen Corp

5.670

+0.210+3.85%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

81 / 207

Overall Ranking

226 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

6.500

Target Price

+23.34%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4675.01.

Overvalued

The company’s latest PE is -1.08, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 240.23M shares, decreasing 15.11% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 23.53M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.77.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 6.59, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 225.46M, representing a year-over-year decrease of 4.79%, while its net profit experienced a year-over-year decrease of 11205.56%.

Score

Industry at a Glance

Previous score

6.59

Change



Financials

5.41

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.26

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.03

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.29

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.95

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -1.08, which is 1.45% below the recent high of -1.10 and -16590.12% above the recent low of -180.99.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 81/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Neogen Corp is 6.50, with a high of 8.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

7.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

6.500

Target Price

+19.05%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Neogen Corp

NEOG

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 6.84, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 5.95 and the support level at 4.93, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.41

Change

0.43

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.081

Neutral

RSI(14)

55.235

Neutral

STOCH(KDJ)(9,3,3)

62.789

Buy

ATR(14)

0.290

High Vlolatility

CCI(14)

6.671

Neutral

Williams %R

24.510

Buy

TRIX(12,20)

0.181

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

5.474

Buy

MA10

5.584

Buy

MA20

5.632

Buy

MA50

5.310

Buy

MA100

5.447

Buy

MA200

7.791

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 110.60%, representing a quarter-over-quarter decrease of 14.46%. The largest institutional shareholder is The Vanguard, holding a total of 23.53M shares, representing 10.83% of shares outstanding, with 8.81% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

28.62M

+23.46%

The Vanguard Group, Inc.

Star Investors

23.51M

+8.86%

Clarkston Capital Partners, LLC

6.28M

+118.93%

Gates Capital Management, Inc.

9.16M

William Blair Investment Management, LLC

13.56M

-5.49%

Dimensional Fund Advisors, L.P.

8.44M

+21.56%

Norges Bank Investment Management (NBIM)

14.81M

-15.27%

State Street Global Advisors (US)

8.61M

+3.40%

Mackenzie Investments

7.76M

-0.87%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 3.07, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.90. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.